Impact of maternal HIV–HBV coinfection on pregnancy outcomes in an underdeveloped rural area of southwest China

Objectives Our objective was to determine the impact of maternal HIV–hepatitis B virus (HBV) coinfection on pregnancy outcomes. Methods The current study was conducted in a county of Yi Autonomous Prefecture in southwest China. Data were abstracted from hospitalisation records, including maternal and infant information. The seroprevalences of HIV and HBV infections and HIV–HBV coinfection were determined and the impact of maternal HIV–HBV coinfection on adverse pregnancy outcomes was assessed using logistic regression analysis. A treatment effects linear regression model was also applied to examine the effect of HBV, HIV or coinfection to quantify the absolute difference in birth weight from a reference of HBV–HIV negative participants. Results A total of 13 198 pregnant women were included in our study, and among them, 99.1% were Yi people and 90.8% lived in rural area. The seroprevalences of HIV and HBV infections and HIV–HBV coinfection were 3.6% (95% CI: 3.2% to 3.9%), 3.2% (95% CI: 2.9% to 3.5%) and 0.2% (95% CI: 0.1% to 0.2%) among the pregnant women, respectively. Maternal HIV–HBV coinfection was a risk factor for low birth weight (adjusted OR (aOR)=5.52, 95% CI: 1.97 to 15.40). Compared with the HIV mono-infection group, the risk of low birth weight was significantly higher in the HIV–HBV coinfection group (aOR=3.62, 95% CI: 1.24 to 10.56). Maternal HIV infection was associated with an increased risk of low birth weight (aOR=1.90, 95% CI: 1.38 to 2.60) and preterm delivery (aOR=2.84, 95% CI: 1.81 to 4.47). Perinatal death was more common when mothers were infected with HBV (aOR=2.85, 95% CI: 1.54 to 5.26). Conclusions The prevalence of HIV infection was high among pregnant women of the Yi region. Both HIV and HBV infections might have adverse effects on pregnancy outcomes. Maternal HIV–HBV coinfection might be a risk factor for low birth weight in the Yi region, which needs to be confirmed.

[1]  Yue Chen,et al.  Impact of maternal HIV infection on pregnancy outcomes in southwestern China – a hospital registry based study , 2019, Epidemiology and Infection.

[2]  R. Heffron,et al.  Maternal Hepatitis B Infection and Pregnancy Outcomes in the United States: A Population-Based Cohort Study , 2018, Open forum infectious diseases.

[3]  R. Tubiana,et al.  HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes , 2017, Journal of acquired immune deficiency syndromes.

[4]  Lanjuan Li,et al.  Hepatitis B virus infection in hilly/mountainous regions of southeastern China: a locality-dependent epidemiology , 2017, BMC Infectious Diseases.

[5]  K. Nelson,et al.  Prevalence of chronic hepatitis B and status of HBV care among rural women who planned to conceive in China , 2017, Scientific Reports.

[6]  Shujuan Yang,et al.  Analysis of HIV prevalence among pregnant women in Liangshan Prefecture, China, from 2009 to 2015 , 2017, PloS one.

[7]  M. Cortina-Borja,et al.  Pregnancy incidence and outcomes in women with perinatal HIV infection , 2017, AIDS.

[8]  M. Bottai,et al.  Pregnancy outcome in more than 5000 births to women with viral hepatitis: a population-based cohort study in Sweden , 2017, European Journal of Epidemiology.

[9]  Z. Henderson,et al.  CDC Grand Rounds: Public Health Strategies to Prevent Preterm Birth. , 2016, MMWR. Morbidity and mortality weekly report.

[10]  J. Hemelaar,et al.  Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. , 2016, The lancet. HIV.

[11]  S. Liang,et al.  Geographical variations in risk factors associated with HIV infection among drug users in a prefecture in Southwest China , 2015, Infectious Diseases of Poverty.

[12]  Deyuan Li,et al.  Association between maternal HBsAg carrier status and neonatal adverse outcomes: meta-analysis , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[13]  Noele P. Nelson,et al.  Outcomes of Infants Born to Women Infected With Hepatitis B , 2015, Pediatrics.

[14]  S. Kim,et al.  Mid-trimester amniotic fluid pro-inflammatory biomarkers predict the risk of spontaneous preterm delivery in twins: a retrospective cohort study , 2015, Journal of Perinatology.

[15]  T. Tongsong,et al.  Pregnancy outcomes among chronic carriers of hepatitis B virus , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[16]  Jun Yu,et al.  Management of chronic hepatitis B infection: current treatment guidelines, challenges, and new developments. , 2014, World journal of gastroenterology.

[17]  D. Jamieson,et al.  HIV-HBV coinfection--a global challenge. , 2012, The New England journal of medicine.

[18]  R. Sperling,et al.  Small for gestational age birth outcomes in pregnant women with perinatally acquired HIV , 2012, AIDS.

[19]  D. Janies,et al.  Different Regions of HIV-1 Subtype C env Are Associated with Placental Localization and In Utero Mother-to-Child Transmission , 2011, Journal of Virology.

[20]  S. Pol,et al.  The impact of human immunodeficiency virus on viral hepatitis , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[21]  H. Rees,et al.  Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study , 2011, Journal of the International AIDS Society.

[22]  F. Emmrich,et al.  Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years , 2010, BMC infectious diseases.

[23]  C. Thio,et al.  Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. , 2007, The Lancet. Infectious diseases.

[24]  Tatsuo Yamamoto,et al.  Transplacental effects of allopurinol on suppression of oxygen free radical production in chronically instrumented fetal lamb brains during intermittent umbilical cord occlusion , 2005, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[25]  M. J. Murphy,et al.  Management of the coinfected patient: human immunodeficiency virus/hepatitis B and human immunodeficiency virus/hepatitis C. , 2004, The American journal of the medical sciences.

[26]  P. Volberding The impact of anemia on quality of life in human immunodeficiency virus-infected patients. , 2002, The Journal of infectious diseases.

[27]  R. Hershow,et al.  Vitamin A Deficiency and Other Nutritional Indices During Pregnancy in Human Immunodeficiency Virus Infection: Prevalence, Clinical Correlates, and Outcome , 1999 .